Comments raise hopes that the vaccine could soon be available to Americans aged 16 and above
US Food and Drug Administration (FDA) staff said on Tuesday that data on Pfizer’s coronavirus vaccine was in line with its guidance on emergency use authorization, raising hopes it could soon be available to Americans aged 16 and above.
The comments were made in documents released ahead of Thursday’s meeting of outside experts to discuss whether the vaccine developed by Pfizer with German pharmaceutical partner BioNTech should be authorized for emergency use in America.
